This study was carried in BSMMU from July 2001 to June 2003. During the study period, 60 pregnant women were studied. Thirty patients were preeclamptic and thirty were normal healthy pregnant women served as control. Serum lipoprotein(a) was found significantly higher in preeclamptic women 56.63±22.6 mg/dl and found within limit in normal healthy pregnant women, 12.89±4.59mg/dl. Result is statistically highly significant (P<0.001). Mean Systolic Blood Pressure was 163.33±29.63 mmHg and 117.00±11.19mmHg in case and control and Diastolic Blood Pressure was 108.53±14.54 mmHg and 76.00±6.87mmHg respectively in case and control group. Result was highly significant as P <0.001. The mean (±SD) serum lipoprotein(a) concentration in normal pregnancies and preeclampsia were found to be 12.91±4.94 and 56.65±22.62. Moderate Proteinuria was found in 77.5% and severe proteinuria in 22.2% cases of preeclampsia respectively. Regardless of mechanism and pathophysiology of preeclampsia, we found high serum level of lipoprotein (a) in preeclampsia patients. These high levels of lipoprotein (a) significantly correlated with blood pressure and proteinuria.
Introduction
Preeclampsia in hypertension associated with proteinuria ≥ 300mg in 24 hours urine or Igm/L in any random sample of urine and with or without oedema occurring primarily in nulliparous women after the 2 nd half of gestation and most frequently near term. Sometimes this turn into essential hypertension l . Preeclampsia occurs in about 5 to 15 percent of the general population 2 .
Characteristic features of severe preeclampsia 3 -1) Blood pressure greater than 164mmHg. 2) Proteinuria exceeding 2gm in a 24-hours, 3) Creatinine (>1.2mg/df), 4) Oliguria <500 ml 24 hours, 5) Cerebral or visual disturbance, Epigastric pain, 7) Elevated liver enzyme, 8) Platelet count <100, 000/mm 3 , 9) Retinal haemorrhage, exudate or papillodema, 10), Pulmonary oedema.
Genetic factors seems to be important in the aetiology of preeclampsia 4 preeclampsia is postulated to be caused by insufficient causing a compromised placental circulation 5 .
Preeclampsia is a serious complication of the second half of pregnancy that occurs with a frequency of upto 15 percent 2 .
Altered coaguability may be important in the pathogenesis of preeclampsia. This study has been designed to measure and analyze the concentrations of lipoprotein (a) level in maternal serum, to find out its significance in the pathogenesis of preeclampsia.
Aims and Objective
General Objectives: Lipoprotein (a) level are elevated in preeclampsia patients and associated with severity of the disease. On the basis of the above hypothesis; a case control study with the aim to determine the role of liproprotein (a) in the pathogenesis of preeclampsia was done. Specific Objectives: a) To determine the level of serum lipoprotein(a) in preeclampsia patients. b) To determine the association of raised lipoprotein(a) with the severity of preeclampsia c) To evaluate; its usefulness in screening for preeclampsia. Serum Lp(a) levels were assayed by Nephelometer agglutination measurement using special Lp(a) assay kit. This method is based on Ag-Ab reaction.
Materials and Methods
All relevant collected data were complied on a master chart first, then organized by using scientific calculator and statistical analysis was done by using computer based software SPSS. Here Chi-square and unpaired Student's 't' test were done to find out probability value. 
Observations & Results

Discussion
The present study dealt with a significant number (n=30) of preeclampsia case where high serum lipoprotein (a) level, i.e. more than 30mgld, which has been set as a cut -Off level, associated with increased of thrombosis and atherosclerosis. 7 None of the normal pregnant women had lipoprotein level more than 30 mg/dl.
In a study on pregnant women showed serum lipoprotein. (a) level as 7.8 mg/dl in control (normal pregnancy), 15.77 mg/dl in women with mild preeclampsia and 82.69mg/dl in women with severe preeclampsia.
2 In our study the serum liproprotein(a) level was 12.91 ±4.94mg/dl in normal pregnancy and 56.65±22.62mg/dl in preeclamptic women.
A rise in blood pressure is the most important clinical criteria to preeclampsia. The result of correlative analysis between serum lipoprotein (a) and their corresponding systolic and diastolic blood, pressure among preeclampsia cases as well as among total study population suggested the significance of high serum lipoprotein (a) in the pathogenesis of preeclampsia. The direct relation between serum lipoprotein (a) and blood pressure obtained in this study corroborate with the hypothesis that increased serum lipoprotein (a) leads to preeclampsia. Among, with rise of systolic and diastolic blood pressure, there is also of serum lipoprotein (a). So, there is direct correlation between severity of preeclampsia and serum lipoprotein(a) level. So, high serum lipoprotein (a) is associated with severity of preeclampsia. Though statistical result do not necessarily reflect, that occurs in vivo the finding in this study indicate a significant role of increased serum lipoprotein(a) in preeclampsia. Conclusion: From the results of this study, it appears that raised level of serum lipoprotein(a) occur in pregnant patients with preeclampsia. At this time, we do not know the exact mechanism of high serum level of lipoprotein(a). Moreover, this study did not show why this high level of lipoprotein(a) play central role to the pathophysiology of preeclampsia. Regardless of we mechanism and pathophysiology of preeclampsia, found high serum level of lipoprotein (a) in preeclampsia patients. These high levels of lipoprotein (a) significantly correlated with blood pressure and proteinuria. Further prospective studies are needed to determine whether a rise in serum lipoprotein(a) can be used as an early predictor of the disease.
